Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics

[Image: see text] Conventional chemotherapeutics remain essential treatments for most cancers, but their combination with other anticancer drugs (including targeted therapeutics) is often complicated by unpredictable synergies and multiplicative toxicities. As cytotoxic anticancer chemotherapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Botham, Rachel C., Roth, Howard S., Book, Alison P., Roady, Patrick J., Fan, Timothy M., Hergenrother, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999974/
https://www.ncbi.nlm.nih.gov/pubmed/27610416
http://dx.doi.org/10.1021/acscentsci.6b00165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999974/
https://www.ncbi.nlm.nih.gov/pubmed/27610416
http://dx.doi.org/10.1021/acscentsci.6b00165

Ejemplares similares